Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-078761
Filing Date
2015-03-05
Accepted
2015-03-05 16:05:36
Documents
12
Period of Report
2015-03-05

Document Format Files

Seq Description Document Type Size
1 6-K d883138d6k.htm 6-K 10257
2 EX-99.1 d883138dex991.htm EX-99.1 32034
3 GRAPHIC g883138ascendis.jpg GRAPHIC 2864
4 GRAPHIC g883138ex99_1pg001.jpg GRAPHIC 22804
5 GRAPHIC g883138ex99_1pg002a.jpg GRAPHIC 29940
6 GRAPHIC g883138ex99_1pg002b.jpg GRAPHIC 27945
7 GRAPHIC g883138ex99_1pg002c.jpg GRAPHIC 9607
8 GRAPHIC g883138ex99_1pg002d.jpg GRAPHIC 14283
9 GRAPHIC g883138ex99_1pg003a.jpg GRAPHIC 24127
10 GRAPHIC g883138ex99_1pg003b.jpg GRAPHIC 53231
11 GRAPHIC g883138ex99_1pg004a.jpg GRAPHIC 23659
12 GRAPHIC g883138ex99_1pg004b.jpg GRAPHIC 26991
  Complete submission text file 0001193125-15-078761.txt   369267
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 15677454
SIC: 2834 Pharmaceutical Preparations